LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

Home・Aandelen Lijst・IQVIA Holdings Inc

IQVIA Holdings Inc

Gesloten

SectorGezondheidszorg

168.23 0.25

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

167.51

Max

169.05

Belangrijke statistieken
By Trading Economics
Inkomsten	-239M 275M
Verkoop	-213M 4.2B
K/W Sectorgemiddelde	21.576 49.701
EPS	2.9
Winstmarge	6.625
Werknemers	93,000
EBITDA	-245M 802M

Aanbevelingen
By TipRanks
Aanbevelingen	Strong Buy
12 Maanden Prognose	+28.65% upside

Dividenden
By Dow Jones
Volgende Winsten	21 jul 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	2B 29B
Vorige openingsprijs	167.98
Vorige sluitingsprijs	168.23

Nieuwssentiment

By Acuity

23%

77%

39 / 345 Rangschikking in Healthcare

IQVIA Holdings Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

24 mei 2026, 23:46 UTC

Marktinformatie

Pullback in Oil Prices Could Temper Inflation Expectations -- Market Talk

24 mei 2026, 23:45 UTC

Marktinformatie

Gold, Silver Rise on Hopes for U.S.-Iran Deal -- Market Talk

24 mei 2026, 23:42 UTC

Marktinformatie

Mineral Resources Bull More Positive Post Site Visit -- Market Talk

24 mei 2026, 23:34 UTC

Marktinformatie

Oil Falls Amid Prospects for Reopening of Strait of Hormuz -- Market Talk

24 mei 2026, 23:11 UTC

Marktinformatie

RBNZ Likely to Stand Pat But Watch for Dissent -- Market Talk

24 mei 2026, 22:26 UTC

Acquisities, Fusies, Overnames

Beach Energy: La Bella 2 Will No Longer Be Drilled as Part of Equinox Campaign

24 mei 2026, 22:25 UTC

Acquisities, Fusies, Overnames

Beach Energy: Implied Transaction Value of Around A$130 Million After Tax

24 mei 2026, 22:25 UTC

Acquisities, Fusies, Overnames

Beach Energy: Royalty Payments Likely to Total Around A$140 Million Based on Resource Booking

24 mei 2026, 22:24 UTC

Acquisities, Fusies, Overnames

Beach Energy to Get Production Royalty of A$3.75/GJ in Deal

24 mei 2026, 22:24 UTC

Acquisities, Fusies, Overnames

Beach Energy to Get A$70 Million Cash Proceeds When Deal Completes

24 mei 2026, 22:23 UTC

Acquisities, Fusies, Overnames

Beach Energy Says Deal Includes Artisan Natural-Gas Discovery

24 mei 2026, 22:23 UTC

Acquisities, Fusies, Overnames

Beach Energy Sells 60% Operated Interest in VIC/L35 Block in Otway Basin

24 mei 2026, 22:11 UTC

Marktinformatie

Oil Price Unlikely to Return to Pre-Conflict Levels This Year -- Market Talk

24 mei 2026, 22:04 UTC

Marktinformatie

Oil Price Likely Lower, Equities Higher on Iran Deal Talks Progress -- Market Talk

23 mei 2026, 08:20 UTC

Marktinformatie

Acquisities, Fusies, Overnames

Financial Services Roundup: Market Talk

23 mei 2026, 08:20 UTC

Marktinformatie

Tech, Media & Telecom Roundup: Market Talk

22 mei 2026, 21:10 UTC

Winsten

These Stocks Are Today's Movers: Dell, Apple, IBM, Estée Lauder, Futu, Rocket Lab, Workday, and More -- Barrons.com

22 mei 2026, 20:50 UTC

Marktinformatie

Tech, Media & Telecom Roundup: Market Talk

22 mei 2026, 20:50 UTC

Marktinformatie

Acquisities, Fusies, Overnames

Financial Services Roundup: Market Talk

22 mei 2026, 20:50 UTC

Marktinformatie

Auto & Transport Roundup: Market Talk

22 mei 2026, 20:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

22 mei 2026, 19:47 UTC

Winsten

Nvidia Has a Plan to Get the Stock Moving Again -- Barrons.com

22 mei 2026, 19:17 UTC

Marktinformatie

U.S. Natural Gas Retreats As Weather Outlook Cools -- Market Talk

22 mei 2026, 19:10 UTC

Marktinformatie

Oil Futures Edge Up Ahead of U.S. Long Weekend -- Market Talk

22 mei 2026, 18:54 UTC

Marktinformatie

Global Equities Roundup: Market Talk

22 mei 2026, 18:54 UTC

Marktinformatie

Kroger Seen Narrowing Pricing Gap Versus Walmart -- Market Talk

22 mei 2026, 18:38 UTC

Marktinformatie

Canada's Population Slowdown Hits Demand for Consumer Companies -- Market Talk

22 mei 2026, 18:35 UTC

Acquisities, Fusies, Overnames

IMAX Might Be Exploring a Sale. Who Could Be Buying. -- Barrons.com

22 mei 2026, 18:09 UTC

Marktinformatie

Centralized Crypto Lending Slows in 1Q -- Market Talk

22 mei 2026, 17:58 UTC

Marktinformatie

U.S. Oil Rig Count Shows Signs of Picking Up -- Market Talk

Peer Vergelijking

Prijswijziging

IQVIA Holdings Inc Prognose

Koersdoel

By TipRanks

28.65% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 216 USD 28.65%

Hoogste 245 USD

Laagste 185 USD

Gebaseerd op 11 Wall Street-analisten die 12-maands prijsdoelen bieden voor IQVIA Holdings Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

11 ratings

Buy

Hold

Sell

Gebaseerd op 11 analisten die aandelenratings hebben gegeven aan IQVIA Holdings Inc - Dist in de afgelopen 3 maanden.

Sentiment

By Acuity

39 / 345 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over IQVIA Holdings Inc

IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a collaboration with argenx SE; and a strategic collaboration with NVIDIA Corporation. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is headquartered in Durham, North Carolina.